DexCom, Inc. (BMV:DXCM)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of MXN 473.60 billion. The enterprise value is 467.11 billion.

Market Cap	473.60B
Enterprise Value	467.11B

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	392.16M
Shares Outstanding	n/a
Shares Change (YoY)	-2.97%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	389.52M

Valuation Ratios

The trailing PE ratio is 43.94 and the forward PE ratio is 27.28.

PE Ratio	43.94
Forward PE	27.28
PS Ratio	5.84
PB Ratio	9.76
P/TBV Ratio	10.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.26, with an EV/FCF ratio of 43.39.

EV / Earnings	43.34
EV / Sales	5.86
EV / EBITDA	26.26
EV / EBIT	36.65
EV / FCF	43.39

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 1.00.

Current Ratio	1.52
Quick Ratio	1.30
Debt / Equity	1.00
Debt / EBITDA	2.69
Debt / FCF	4.52
Interest Coverage	36.17

Financial Efficiency

Return on equity (ROE) is 22.83% and return on invested capital (ROIC) is 8.44%.

Return on Equity (ROE)	22.83%
Return on Assets (ROA)	6.08%
Return on Invested Capital (ROIC)	8.44%
Return on Capital Employed (ROCE)	17.10%
Revenue Per Employee	7.91M
Profits Per Employee	1.05M
Employee Count	10,300
Asset Turnover	0.61
Inventory Turnover	3.05

Taxes

In the past 12 months, DexCom has paid 4.01 billion in taxes.

Income Tax	4.01B
Effective Tax Rate	27.11%

Stock Price Statistics

The stock price has decreased by -8.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.44%
50-Day Moving Average	1,462.96
200-Day Moving Average	2,071.12
Relative Strength Index (RSI)	35.36
Average Volume (20 Days)	305

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.78

Income Statement

In the last 12 months, DexCom had revenue of MXN 81.11 billion and earned 10.78 billion in profits. Earnings per share was 26.97.

Revenue	81.11B
Gross Profit	47.66B
Operating Income	12.96B
Pretax Income	14.79B
Net Income	10.78B
EBITDA	17.41B
EBIT	12.96B
Earnings Per Share (EPS)	26.97

Balance Sheet

The company has 55.24 billion in cash and 48.64 billion in debt, giving a net cash position of 6.60 billion.

Cash & Cash Equivalents	55.24B
Total Debt	48.64B
Net Cash	6.60B
Net Cash Per Share	n/a
Equity (Book Value)	48.52B
Book Value Per Share	123.72
Working Capital	32.46B

Cash Flow

In the last 12 months, operating cash flow was 18.63 billion and capital expenditures -7.86 billion, giving a free cash flow of 10.76 billion.

Operating Cash Flow	18.63B
Capital Expenditures	-7.86B
Free Cash Flow	10.76B
FCF Per Share	n/a

Margins

Gross margin is 58.77%, with operating and profit margins of 15.98% and 13.29%.

Gross Margin	58.77%
Operating Margin	15.98%
Pretax Margin	18.23%
Profit Margin	13.29%
EBITDA Margin	21.47%
EBIT Margin	15.98%
FCF Margin	13.27%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.97%
Shareholder Yield	n/a
Earnings Yield	2.28%
FCF Yield	2.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 5.47 and a Piotroski F-Score of 6.

Altman Z-Score	5.47
Piotroski F-Score	6